CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Peer review reports

Original Submission
21 Dec 2017	Submitted	Original manuscript
20 Feb 2018	Author responded	Author comments - Dean Fennell
Resubmission - Version 2
20 Feb 2018	Submitted	Manuscript version 2
15 Mar 2018	Reviewed	Reviewer Report - Shelley Potter
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
15 Mar 2018	Editorially accepted
18 Apr 2018	Article published	10.1186/s13063-018-2602-y

Back to article page